The global demand for Rofecoxib Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period of 2022 - 2028. Regarding volume, the market was calculated XX Ton in 2021 and forecast to touch XX Ton by 2028 with a CAGR of XX% during 2022-2028.
Rofecoxib is a cyclooxygenase (COX-2) selective non-steroidal anti-inflammatory drug (NSAID). It is currently widespread prescribed by physicians to treat acute and chronic symptoms of osteoarthritis, rheumatoid arthritis, acute pain, migraine, dysmenorrhea, and menstrual pain. Rofecoxib helps relieve signs and symptoms of pain and inflammation. Rofecoxib is available by prescription in both tablet-form and as an oral suspension. It is sold under the brand names Vioxx, Ceoxx, and Ceeoxx.
Market Dynamics
The rising aging population and the growing burden of chronic pain and acute pain drive the global rofecoxib market. According to UN Report, globally, there were 727 million individuals aged 65 years or over in 2020. The share of the people aged 65 years or above is predicted to rise from 9.3 5 in 2020 to around 16.0 % in 2050. This will positively impact the global rofecoxib market. Moreover, it has been estimated that 1 in 5 adults suffer from pain, and another 1 in 10 adults is diagnosed with chronic pain each year globally. Changing lifestyle, growing risk factors, and increasing life expectancy are other factors influencing demand for Rofecoxib. However, access to other anti-inflammatory drugs is hampering the global rofecoxib market.
The report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of rofecoxib. The growth and trends of Rofecoxib Industry provide a holistic approach to this study.
Market Segmentation
This section of the rofecoxib market report provides detailed data on the segments by analyzing them at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
- Oral Suspension
- Tablet-Form
By Application
- Osteoarthritis
- Rheumatoid Arthritis
- Juvenile Rheumatoid Arthritis
- Acute Pain Conditions
- Migraine
- Dysmenorrhea
- Others
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Rofecoxib market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Rofecoxib Market Share by Region (Representative Graph)
Know more about this report: Download free sample
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the rofecoxib market include Merck, Chengdu Meinkai Chemical Co. LTD, Wuhan Xinxin Jiali Biotechnology Co. LTD, Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD, Pfizer, Tremeau This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.